Menu

Septerna, Inc. (SEPN) Presents at UBS Global Biopharma Conference 2026 Transcript
📰

Septerna, Inc. (SEPN) Presents at UBS Global Biopharma Conference 2026 Transcript

All Articles on Seeking Alpha·about 6 hours ago
#fMueycdt
Reading 0:00
15s threshold

Septerna, Inc. ( SEPN ) UBS Global Biopharma Conference 2026 November 16, 2026 9:00 AM EST

Company Participants

Jeffrey Finer - Co-Founder, CEO & Director

Liz Bhatt - President & COO

Conference Call Participants

Alice Nettleton

Presentation

Alice Nettleton

Good afternoon, everybody. Welcome to the next session at the UBS Global Biopharma Conference. I'm Alice Nettleton, one of the SMID biotech analysts at UBS. Happy to introduce the team from Septerna, Jeff Finer, CEO and Co-Founder; and Liz Bhatt, President and COO. Great to see you, Jeff and Liz. Thank you so much for joining us.

To start off, I'll hand it over to Jeff to go through some slides for a presentation for maybe 15 minutes, and then we'll have a Q&A after that.

Jeffrey Finer

Co-Founder, CEO & Director

Okay. Thanks, Alice, and thanks to the UBS team for inviting us. So for those of you who aren't familiar with Septerna, we're a company focused entirely on GPCRs or G protein-coupled receptors.…

Continue reading — create a free account

Join HashtagPLUS to read full articles, follow hashtags, vote, and join the conversation.